These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32626839)

  • 41. An update on the recent advances in antifibrotic therapy.
    Tacke F; Weiskirchen R
    Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1143-1152. PubMed ID: 30261763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of aging on liver microcirculatory function and sinusoidal phenotype.
    Maeso-Díaz R; Ortega-Ribera M; Fernández-Iglesias A; Hide D; Muñoz L; Hessheimer AJ; Vila S; Francés R; Fondevila C; Albillos A; Peralta C; Bosch J; Tacke F; Cogger VC; Gracia-Sancho J
    Aging Cell; 2018 Dec; 17(6):e12829. PubMed ID: 30260562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Numerical simulation of flow characteristics in a permeable liver sinusoid with leukocytes.
    Chen S; Zhu J; Xue J; Wang X; Jing P; Zhou L; Cui Y; Wang T; Gong X; Lü S; Long M
    Biophys J; 2022 Dec; 121(23):4666-4678. PubMed ID: 36271623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.
    Le Couteur DG; Fraser R; Hilmer S; Rivory LP; McLean AJ
    Clin Pharmacokinet; 2005; 44(2):187-200. PubMed ID: 15656697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic alcohol feeding in liquid diet or in drinking water has similar effects on electron microscopic appearance of the hepatic sinusoid in the rat.
    Sarphie TG; D'Souza NB; Spitzer JJ; Deaciuc IV
    Alcohol Clin Exp Res; 1996 Sep; 20(6):973-9. PubMed ID: 8892514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [An update of understanding of the hepatic vascular system and new research strategies].
    Lin Y; Liu Z; Dong M; Zhou W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1907-1911. PubMed ID: 36651262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrophage Phenotype and Function in Liver Disorder.
    Dou L; Shi X; He X; Gao Y
    Front Immunol; 2019; 10():3112. PubMed ID: 32047496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells.
    Kiagiadaki F; Kampa M; Voumvouraki A; Castanas E; Kouroumalis E; Notas G
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):891-899. PubMed ID: 29287776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
    Powell EE; Cooksley WG; Hanson R; Searle J; Halliday JW; Powell LW
    Hepatology; 1990 Jan; 11(1):74-80. PubMed ID: 2295475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis.
    Seen TK; Sayed M; Bilal M; Reyes JV; Bhandari P; Lourdusamy V; Al-Khazraji A; Syed U; Sattar Y; Bansal R
    World J Gastroenterol; 2021 Jun; 27(23):3238-3248. PubMed ID: 34163108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice.
    Kong LJ; Li H; Du YJ; Pei FH; Hu Y; Zhao LL; Chen J
    Mol Med Rep; 2017 May; 15(5):2604-2610. PubMed ID: 28447731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD).
    Subramanian P; Hampe J; Tacke F; Chavakis T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "The sinusoid" in the liver: lessons learned from the original definition by Charles Sedgwick Minot (1900).
    Wake K; Sato T
    Anat Rec (Hoboken); 2015 Dec; 298(12):2071-80. PubMed ID: 26332299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrosis in alcoholic and nonalcoholic steatohepatitis.
    Bataller R; Rombouts K; Altamirano J; Marra F
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
    Robinson KE; Shah VH
    Transl Gastroenterol Hepatol; 2020; 5():49. PubMed ID: 33073044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
    Harrison SA; Abdelmalek MF; Caldwell S; Shiffman ML; Diehl AM; Ghalib R; Lawitz EJ; Rockey DC; Schall RA; Jia C; McColgan BJ; McHutchison JG; Subramanian GM; Myers RP; Younossi Z; Ratziu V; Muir AJ; Afdhal NH; Goodman Z; Bosch J; Sanyal AJ;
    Gastroenterology; 2018 Oct; 155(4):1140-1153. PubMed ID: 29990488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021.
    Ding WX; Wang H; Zhang Y
    Liver Res; 2022 Mar; 6(1):50-57. PubMed ID: 35747395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice.
    Wu Y; Li Z; Xiu AY; Meng DX; Wang SN; Zhang CQ
    Drug Des Devel Ther; 2019; 13():2667-2676. PubMed ID: 31534314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
    Kim TH; Banini BA; Asumda FZ; Campbell NA; Hu C; Moser CD; Shire AM; Han S; Ma C; Krishnan A; Mounajjed T; White TA; Gores GJ; LeBrasseur NK; Charlton MR; Roberts LR
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G333-G344. PubMed ID: 32683952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.